0001209191-19-041996.txt : 20190712
0001209191-19-041996.hdr.sgml : 20190712
20190712194618
ACCESSION NUMBER: 0001209191-19-041996
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190710
FILED AS OF DATE: 20190712
DATE AS OF CHANGE: 20190712
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SVF Investments (UK) Ltd
CENTRAL INDEX KEY: 0001716729
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34949
FILM NUMBER: 19953870
BUSINESS ADDRESS:
STREET 1: 69 GROSVENOR STREET
CITY: LONDON
STATE: X0
ZIP: W1K3JP
BUSINESS PHONE: 6508435214
MAIL ADDRESS:
STREET 1: 69 GROSVENOR STREET
CITY: LONDON
STATE: X0
ZIP: W1K3JP
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SoftBank Vision Fund L.P.
CENTRAL INDEX KEY: 0001699940
STATE OF INCORPORATION: Y9
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34949
FILM NUMBER: 19953871
BUSINESS ADDRESS:
STREET 1: AZTEC GROUP HOUSE
STREET 2: 11-15 SEATON PLACE
CITY: ST HELIER
STATE: Y9
ZIP: JE4 0QH
BUSINESS PHONE: 44 1534 833000
MAIL ADDRESS:
STREET 1: AZTEC GROUP HOUSE
STREET 2: 11-15 SEATON PLACE
CITY: ST HELIER
STATE: Y9
ZIP: JE4 0QH
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SVF Holdings (UK) LLP
CENTRAL INDEX KEY: 0001716727
STATE OF INCORPORATION: CA
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34949
FILM NUMBER: 19953872
BUSINESS ADDRESS:
STREET 1: 69 GROSVENOR STREET
CITY: LONDON
STATE: X0
ZIP: W1K3JP
BUSINESS PHONE: 6508435214
MAIL ADDRESS:
STREET 1: 69 GROSVENOR STREET
CITY: LONDON
STATE: X0
ZIP: W1K3JP
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SVF GP (Jersey) Ltd
CENTRAL INDEX KEY: 0001716728
STATE OF INCORPORATION: Y9
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34949
FILM NUMBER: 19953873
BUSINESS ADDRESS:
STREET 1: AZTEC GROUP HOUSE
STREET 2: 11-15 SEATON PLACE
CITY: ST. HELIER
STATE: Y9
ZIP: JE4OQH
BUSINESS PHONE: 6508435214
MAIL ADDRESS:
STREET 1: AZTEC GROUP HOUSE
STREET 2: 11-15 SEATON PLACE
CITY: ST. HELIER
STATE: Y9
ZIP: JE4OQH
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arbutus Biopharma Corp
CENTRAL INDEX KEY: 0001447028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980597776
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
BUSINESS PHONE: 604-419-3200
MAIL ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp
DATE OF NAME CHANGE: 20110607
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20081003
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-07-10
1
0001447028
Arbutus Biopharma Corp
ABUS
0001716729
SVF Investments (UK) Ltd
69 GROSVENOR STREET
LONDON
X0
W1K 3JP
UNITED KINGDOM
0
0
0
1
Former 10% Owner
0001699940
SoftBank Vision Fund L.P.
AZTEC GROUP HOUSE
11-15 SEATON PLACE
ST. HELIER
X0
JE4 0QH
UNITED KINGDOM
0
0
0
1
Former 10% Owner
0001716727
SVF Holdings (UK) LLP
69 GROSVENOR STREET
LONDON
X0
W1K 3JP
UNITED KINGDOM
0
0
0
1
Former 10% Owner
0001716728
SVF GP (Jersey) Ltd
AZTEC GROUP HOUSE
11-15 SEATON PLACE
ST. HELIER
X0
JE4 0QH
UNITED KINGDOM
0
0
0
1
Former 10% Owner
This Form 4 relates to the Common Shares, no par value per share (the "Common Shares"), of Arbutus Biopharma Corporation (the "Issuer"). On July 10, 2019, the board of directors of Roivant Sciences Ltd. ("Roivant") adopted changes to Roivant's internal governance concerning the disposition of the Common Shares and other matters relating to oversight of Roivant's business and governance. As a result of these changes, the Reporting Persons and other major shareholders of Roivant no longer have the individual right to veto dispositive decisions of Roivant's board of directors regarding disposition of the Common Shares, and so have ceased to have beneficial ownership of the Common Shares directly owned by Roivant. Roivant's ownership of the Issuer's Common Shares remains unchanged and this filing is not being made as a result of the purchase or sale of Common Shares of the Issuer by any party, including the Reporting Persons.
/s/ Karen Ubell, Attorney-in-Fact
2019-07-12
/s/ Karen Ubell, Attorney-in-Fact
2019-07-12
/s/ Karen Ubell, Attorney-in-Fact
2019-07-12
/s/ Karen Ubell, Attorney-in-Fact
2019-07-12